Controlled Human Infection Study of Orally Administered Trichuris Trichiura Eggs in Naïve Adults

PHASE1RecruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

October 23, 2026

Study Completion Date

April 30, 2028

Conditions
WhipwormTrichuriasisControlled Human Infection
Interventions
BIOLOGICAL

Trichuris trichiura Egg Inoculum

Trichuris trichiura Egg Inoculum that will be used in this study is manufactured by obtaining T. trichiura eggs from the feces of a chronically infected human volunteer, who is negative for HIV, HBV, and HCV. Fecal material is processed following a qualified standard procedure, and after isolating eggs, they are stored at 2-8oC until use. Controls for the manufacturing process are tests for viability (microscopy of larval hatching), species identification (PCR), and microbial bioburden of the eggs.

Trial Locations (2)

20037

RECRUITING

George Washington University Medical Faculty Associates, Washington D.C.

20892

RECRUITING

NIH Clinical Center, Bethesda

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

George Washington University

OTHER

NCT05706116 - Controlled Human Infection Study of Orally Administered Trichuris Trichiura Eggs in Naïve Adults | Biotech Hunter | Biotech Hunter